Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Kevin Marsh, Director of the Africa Oxford Initiative, Professor of Tropical Medicine at the University of Oxford, and Senior Advisor at the African Academy of Sciences has been selected to receive a Drexel Prize for scientific excellence.

Prof Marsh, together with 6 other prize winners will receive their awards and give talks during the 2017 International Symposium on Molecular Medicine and Infectious Disease in Philadelphia, USA.

His major research interests have been in the acquisition of human immunity to malaria and its interplay in determining the clinical and epidemiological picture of the disease. In 1989, he established a series of research projects on Malaria in Kilifi, Kenya with his colleagues which subsequently developed into the KEMRI Wellcome Trust Research Programme – an international interdisciplinary program addressing many aspects of public health with more than 800 staff working across East Africa.

Read more (Africa Oxford Initiative website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.